Numbers by Barron's

A Fourth Covid-19 Vaccine in the U.S. Looks Likely

06.08.2022 - By Barron'sPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

The FDA clears a path for Novavax. Franchise Group is in talks to buy Kohl’s. And Target’s surplus inventory is causing headaches.

Host: Jackson Cantrell.

Learn more about your ad choices. Visit megaphone.fm/adchoices

More episodes from Numbers by Barron's